GCC Cancer Therapeutics Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
No. of Pages: 150 | Report Code: BMIRE00031445 | Category: Life Sciences
No. of Pages: 150 | Report Code: BMIRE00031445 | Category: Life Sciences
The Cancer Therapeutics Market size is expected to reach US$ 2,849.15 million by 2031 from US$ 1,238.50 million in 2024. The market is estimated to record a CAGR of 10.9% from 2025 to 2031.
The cancer therapeutics market in GCC is experiencing significant growth driven by several key factors, including significant advancements in healthcare infrastructure and an increase in the prevalence of cancer. The region is known for its economic wealth, and it has made strides in developing its healthcare sector to meet the rising demands of its aging population. Owing to the continuous evolution of healthcare systems, rising cancer incidence, burgeoning government support, and an increased focus on cancer care, the GCC region is experiencing substantial growth in the cancer therapeutics market. The demand for innovative cancer treatment modalities such as immunotherapies and personalized medicine is rising in GCC countries, and investments in healthcare systems and awareness programs are aiding in improved access to these therapies.
Key segments that contributed to the derivation of the cancer therapeutics market analysis are therapy type, indication, and distribution channel.
A significant rise in cancer cases in the region drives the need for cancer therapeutics. According to the government of UAE, ~4,500 new cases of cancer are reported every year in the country. The International Agency for Research on Cancer stated that the UAE recorded 4,807 new cancer cases in 2020. As per GLOBOCAN 2020 data, the country recorded ~1,030 new breast cancer cases, representing 21.4% of all new cases. The demand for cancer treatments, both conventional and innovative, is surging due to increasing cancer cases, coupled with an aging population and lifestyle factors that contribute to cancer risks, such as smoking and poor dietary habits.
Governments of various countries of the GCC are investing heavily in healthcare infrastructure and cancer control programs. For instance, the government of Kuwait has been actively investing in efforts to enhance the cancer treatment infrastructure. The Ministry of Health (MOH) has prioritized cancer care by establishing specialized treatment centers such as the Kuwait Cancer Control Center, which provides a wide range of services, including chemotherapy and immunotherapy. In October 2021, the National Bank of Kuwait (NBK) launched an annual campaign during breast cancer awareness month to promote women's health. The campaign is part of the Bank's ongoing campaign to raise social awareness regarding breast cancer and promote its ways of prevention.
Based on region, the Gulf Cooperation Council (GCC) cancer therapeutics market is further segmented into Saudi Arabia, UAE, Kuwait, Oman, Qatar, and Bahrain. Saudi Arabia held the largest share in 2024.
The growth of the cancer therapeutics market in Saudi Arabia is driven by rising cancer incidence, growing healthcare infrastructure, and an increasing aging population. Saudi Arabia has been experiencing an upsurge in the incidence of cancer; the number of cancer-related deaths has also increased in the country. As per GLOBOCAN 2020 data, the country recorded ~27,885 new cancer cases, and the number is expected to rise to 60,429 by 2040. Also, the number of people aged 80 or more is expected to reach 1.6 million, i.e., 4% of the total population by 2050. Lifestyle changes such as increased tobacco use and poor dietary habits further elevate cancer risk in the Saudi population.
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 1,238.50 Million |
| Market Size by 2031 | US$ 2,849.15 Million |
| Global CAGR (2025 - 2031) | 10.9% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Therapy Type
|
| Regions and Countries Covered | GCC
|
Astellas Pharma Inc; Eli Lilly and Co; Novartis AG; Merck KGaA.; Johnson & Johnson; AstraZeneca; Julphar Pharmaceuticals; Bristol Myers Squibb; SPIMACO ADDWAEIH; and Gulf Investment Corporation are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.
The following methodology has been followed for the collection and analysis of data presented in this report:
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Note:
All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:
Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:
The GCC Cancer Therapeutics Market is valued at US$ 1,238.50 Million in 2024, it is projected to reach US$ 2,849.15 Million by 2031.
As per our report GCC Cancer Therapeutics Market, the market size is valued at US$ 1,238.50 Million in 2024, projecting it to reach US$ 2,849.15 Million by 2031. This translates to a CAGR of approximately 10.9% during the forecast period.
The GCC Cancer Therapeutics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the GCC Cancer Therapeutics Market report:
The GCC Cancer Therapeutics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The GCC Cancer Therapeutics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the GCC Cancer Therapeutics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For GCC Cancer Therapeutics Market
